Eledon Pharmaceuticals, Inc.
ELDNFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Eledon Pharmaceuticals, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 13 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jan 16, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| CITIGROUP INC | 2026-03-31 | 3,498 | Not shown | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 36,569 | Not shown | SEC filing |
| Invesco Ltd. | 2026-03-31 | 30,968 | Not shown | SEC filing |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2026-03-31 | 35,054 | Not shown | SEC filing |
| Addison Advisors LLC | 2026-03-31 | 1,300 | Not shown | SEC filing |
| VOYA INVESTMENT MANAGEMENT LLC | 2026-03-31 | 13,216 | Not shown | SEC filing |
| Ellis Investment Partners, LLC | 2026-03-31 | 10,000 | Not shown | SEC filing |
| PNC FINANCIAL SERVICES GROUP, INC. | 2026-03-31 | 937 | Not shown | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 24,600 | Not shown | SEC filing |
| RHUMBLINE ADVISERS | 2026-03-31 | 47,626 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 4,249 | Not shown | SEC filing |
| BVF INC/IL | 2026-03-31 | 6,293,282 | Not shown | SEC filing |
| Root Financial Partners, LLC | 2026-03-31 | 110 | Not shown | SEC filing |
| Clearstead Advisors, LLC | 2026-03-31 | 500 | Not shown | SEC filing |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-03-31 | 4,094 | Not shown | SEC filing |
| Rockefeller Capital Management L.P. | 2026-03-31 | 71,666 | Not shown | SEC filing |
| Zimmer Partners, LP | 2026-03-31 | 1,875,000 | Not shown | SEC filing |
| GROUP ONE TRADING LLC | 2026-03-31 | 29,874 | Not shown | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 16,053 | Not shown | SEC filing |
| LPL Financial LLC | 2026-03-31 | 74,960 | Not shown | SEC filing |
- Each value is checked against Eledon Pharmaceuticals, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- CM Management, LLC: 650,000 shares reported 2025-12-31; 650,000 shares reported 2026-03-31.
- VOYA INVESTMENT MANAGEMENT LLC: 11,420 shares reported 2025-12-31; 13,216 shares reported 2026-03-31.
116 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Eledon Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-05-09 · BVF PARTNERS L P/IL (derivative): Larger than all 8 other insider purchases of Pre-funded Warrants to Purchase Common Stock on file. SEC filing
- 2020-12-02 · OrbiMed Israel GP Ltd.: Larger than all 29 other insider sales of Common Stock on file. SEC filing
- 2019-05-02 · OrbiMed Israel GP Ltd.: Larger than 20 of the 21 other insider purchases of Common Stock on file. SEC filing
- 2019-05-02 · Chimovits Erez: Larger than 20 of the 21 other insider purchases of Common Stock on file. SEC filing
- 2017-05-10 · FLESHER GREGORY J.: Larger than 19 of the 21 other insider purchases of Common Stock on file. SEC filing
- 2015-06-11 · NOVARTIS AG: Larger than 27 of the 29 other insider sales of Common Stock on file. SEC filing
- 2015-03-19 · NOVARTIS AG: Larger than 28 of the 29 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2021-06-09–2021-06-11: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2019-05-02–2019-05-02: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2019-05-02–2019-05-02: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2017-05-10–2017-05-10: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2024-10-29 | BVF PARTNERS L P/IL · 10% owner | Pre-funded Warrants to Purchase Common Stock | P — Open market or private purchase | +2,213,816 | 3.65 | SEC filing |
| 2024-10-29 | BVF PARTNERS L P/IL · 10% owner | Pre-funded Warrants to Purchase Common Stock | P — Open market or private purchase | +2,100,244 | 3.65 | SEC filing |
| 2024-10-29 | BVF PARTNERS L P/IL · 10% owner | Pre-funded Warrants to Purchase Common Stock | P — Open market or private purchase | +440,489 | 3.65 | SEC filing |
| 2024-05-09 | BVF PARTNERS L P/IL · 10% owner | Pre-funded Warrants to Purchase Common Stock | P — Open market or private purchase | +232,068 | unknown | SEC filing |
| 2024-05-09 | BVF PARTNERS L P/IL · 10% owner | Common Stock, $0.001 par value | P — Open market or private purchase | +75,431 | unknown | SEC filing |
| 2024-05-09 | BVF PARTNERS L P/IL · 10% owner | Pre-funded Warrants to Purchase Common Stock | P — Open market or private purchase | +3,173,135 | unknown | SEC filing |
| 2024-05-09 | BVF PARTNERS L P/IL · 10% owner | Common Stock, $0.001 par value | P — Open market or private purchase | +1,031,385 | unknown | SEC filing |
| 2024-05-09 | BVF PARTNERS L P/IL · 10% owner | Pre-funded Warrants to Purchase Common Stock | P — Open market or private purchase | +2,526,238 | unknown | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2035-01-10 | Robinson James A. Jr. · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +30,870 | SEC filing |
| 2026-01-10 | Kirk Allan · Director | Common Stock | M — Exercise or conversion of derivative security | +3,430 | SEC filing |
| 2026-01-10 | Robinson James A. Jr. · Director | Common Stock | M — Exercise or conversion of derivative security | +3,430 | SEC filing |
| 2026-01-10 | Kirk Allan · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −3,430 | SEC filing |
| 2026-01-10 | Hillson Jan · Director | Common Stock | M — Exercise or conversion of derivative security | +3,430 | SEC filing |
| 2026-01-10 | Katkin Keith · Director | Common Stock | M — Exercise or conversion of derivative security | +8,575 | SEC filing |
| 2026-01-10 | Hillson Jan · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −3,430 | SEC filing |
| 2026-01-10 | Katkin Keith · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −8,575 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.